Portfolio Companies

  • AI/ML Ops
    Architecture, Engineering, and Construction
    B2B GTM
    B2C MarTech & Customer Support
    BioTech/Therapeutics
    Consumer
    Cybersecurity
    Data & Data Mgmt.
    DevOps
    eCommerce Enablement
    Education
    Energy & Climate
    Finance & Accounting
    Financial Services
    Gaming
    Government
    Healthcare
    Human Capital
    IT Mgmt
    Legal & Compliance
    Manufacturing
    Marketplace
    Other Vertical Market SaaS
    Payments
    Product & Process Management
    Real Estate
    Supply Chain & Logistics
    Web3
  • North America
    Africa
    Western Europe
    Eastern Europe
    Asia Pacific
    Israel
    South America
  • Current Investment
    Prior Investment

Limerick, No Data Available, Ireland

Amsterdam, No Data Available, Netherlands

Tel Aviv, No Data Available, Israel

Bonn, No Data Available, Germany

Miami, Florida, U.S.

San Francisco, California, U.S.

Insight Partners is an awesome firm that shares many of our values, and we’ve been grateful to have them as partners on this journey of building a great company based on a great product.
Eran Zinman
Co-Founder & CEO Monday.com*

London, No Data Available, U.K.

Lehi, Utah, U.S.

Farmington, Utah, U.S.

Espressive logo

San Francisco, California, U.S.

Wilmington, North Carolina, U.S.

San Francisco, California, U.S.

Dotmatics (FKA Insightful Science GraphPad)

Accelerating Scientific Discovery Through Data Integration

Dotmatics is a leading scientific R&D platform that enables global life sciences organizations to centralize, visualize, and act on complex scientific data. By bridging historically siloed research systems, Dotmatics empowers scientists to accelerate innovation in drug discovery, biologics, and materials science. 



Insight’s Investment Journey 


- 2020: Insight Partners invested in Dotmatics, recognizing the opportunity to build a unified, data-driven platform for scientific research. 


- 2021: Dotmatics merged with BioBright, LabArchives, and other Insight-backed companies, forming a powerful end-to-end solution for R&D data integration and informatics. 



A Strategic Exit 


In 2024, Dotmatics entered into a definitive agreement to be acquired by Siemens, marking a major milestone in its evolution and validating its role as a core infrastructure player in global R&D. 


The acquisition further solidifies Dotmatics’ position at the intersection of scientific innovation and industrial digitization. 



Dotmatics by the Numbers 


- Trusted by 15 of the top 20 global pharmaceutical companies.

- Powers research for 2+ million scientists worldwide.

- Offers integrated solutions across ELN, LIMS, analytics, and data management.



Enabling the Future of Scientific Research 


With Insight Partners’ strategic investment and platform-building support, Dotmatics evolved from a specialized software provider into a global leader in scientific informatics—and is now poised to scale even further as part of Siemens’ portfolio. 

Investment Team Jared Rosen Peter Segall Jeff Lieberman
Sectors Healthcare Pharma
Initial Investment November 2017
Status Current Investment